Nuke-imaging supplier spikes prices, draws watchdog’s attention

12:26 EDT 30 Jun 2017 | TriMed Media Group


The India-headquartered manufacturer of radiotracers used in nuclear imaging has come under the watchful eye of an American journalist for its alleged price gouging and possibly improper product bundling.

Pharma watcher Ed Silverman of STAT reports that the company, Jubilant DraxImage, has spiked prices for two of its imaging agents between 500 percent and nearly 1,800 percent while also pressuring its pharmacy clients to sign long-term contracts with minimum-purchase clauses.

“The Jubilant contracts that went into force earlier this year prevent the pharmacies from engaging in what is called anticipatory compounding,” Silverman writes. “As a result, the pharmacies can only purchase enough of the Jubilant medicines to fill specific orders and, unless a hospital orders several doses, any leftover medicine is likely to be wasted. The upshot: Pharmacies must spend more to keep customers.”

Silverman notes that Jubilant has been reported to state and federal authorities but says there are no signs any investigations have been launched.

The piece was picked up by PBS. Click to read:

Author Reference: 
Content Type: 
Top Story: 

Original Article: Nuke-imaging supplier spikes prices, draws watchdog’s attention


More From BioPortfolio on "Nuke-imaging supplier spikes prices, draws watchdog’s attention"

Quick Search


Relevant Topic

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...